TRP_1170x120_3-8-19

human papillomavirus

Merck OK’d for Gardasil 9 expanded age indication

Merck OK’d for Gardasil 9 expanded age indication

KENILWORTH, N.J. — Merck has received approval from the Food and Drug Administration for an expanded age indication for Gardasil 9, its 9-valent human papillomavirus (HPV) vaccine. The company said the new indication allows Gardasil 9 to include use in males ages 16 to 26 years for the prevention of anal cancer caused by HPV